Cellectar Biosciences, Inc.
CLRB
$2.37
-$0.05-1.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 207.89% | -39.97% | -43.34% | -63.36% | -57.32% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.95% | -6.84% | -12.41% | -34.75% | -22.58% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 176.42% | -37.77% | -42.11% | -62.06% | -54.78% |
|
|
|||||
| Total Current Assets | 176.42% | -37.77% | -42.11% | -62.06% | -54.78% |
| Net Property, Plant & Equipment | 65.86% | 62.80% | -23.78% | -28.45% | -27.71% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.81% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 167.53% | -30.68% | -41.20% | -60.78% | -53.39% |
|
|
|||||
| Total Accounts Payable | 11.54% | 21.95% | -64.91% | -51.66% | -27.61% |
| Total Accrued Expenses | -- | -- | 14.52% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -97.83% | -- | 18.72% | 18.81% | 19.02% |
| Total Finance Division Other Current Liabilities | -98.45% | -92.76% | -76.06% | -93.28% | -87.30% |
| Total Other Current Liabilities | -98.45% | -92.76% | -76.06% | -93.28% | -87.30% |
| Total Current Liabilities | -10.72% | -19.05% | -49.41% | -75.82% | -61.32% |
|
|
|||||
| Total Current Liabilities | -10.72% | -19.05% | -49.41% | -75.82% | -61.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 323.10% | 295.86% | -24.46% | -22.23% | -20.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.66% | -0.06% | -48.36% | -74.70% | -60.13% |
|
|
|||||
| Common Stock & APIC | 17.60% | 6.08% | 6.14% | 10.05% | 12.82% |
| Retained Earnings | -8.61% | -8.21% | -8.81% | -7.69% | -12.62% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 436.86% | -63.60% | -41.80% | 382.54% | 22.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 0.00% | 0.00% | -87.31% | -79.37% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 0.00% | 0.00% | -87.31% | -79.37% |
|
|
|||||
| Total Common Equity | 436.86% | -63.60% | -41.80% | 382.54% | 22.63% |
| Total Preferred Equity | -- | 0.00% | 0.00% | -87.31% | -79.37% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 300.05% | -51.04% | -36.73% | -43.32% | -45.75% |
|
|
|||||